Redcliffe Labs founder discusses new era of diagnostics in India

D.JainD.Jain
BulletArticle
RED 2022 C-Suite Perspectives
共有する：
リンクをコピーする
Redcliffe Labs founder discusses new era of diagnostics in India_thumbnail

Since its inception in 2018, Redcliffe Labs has endeavoured to be a disrupter in India’s lab diagnostics ecosystem. In this talk at RED 2022, founder and managing director Dheeraj Jain discusses some of the company’s key strategic initiatives, such as the use of temperature controlled transport bags and an AI/ML supported infrastructure with a complete ‘Glucose to Genetics’ approach.

共有する：
リンクをコピーする

同じトピックの記事

How 5G enables telemedicine: Taiwan’s success story

Virtual reference site visit: Changi General Hospital Singapore

おすすめのトピック

SequencingRED 2020Rare Diseases
次のおすすめ記事
‘Real world evidence’ and clinical labs: a brief introduction
  • Healthcare Transformation, Management, Operations, Population Health Management
‘Real world evidence’ and clinical labs: a brief introduction
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
  • Disease Area, Healthcare Transformation, Histopathology, Leaders In Conversation, Management, Oncology, Operations
‘Chasing the Invisible’ and the future of the clinical lab: Q&A with Dr Thomas Grogan (Part 3)
3 steps to mitigate the impact of interference
  • Clinician Engagement, Coagulation, Disease Area, Management
3 steps to mitigate the impact of interference
A guide to balancing quality, speed and cost
  • Operational Excellence, Operations
A guide to balancing quality, speed and cost
Scroll to Top